ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION explained in plain language.
Never miss a new study
Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION trials appear
Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Diabetes pill may shield transplant patients from dangerous rejection
Disease control CompletedThis study tested if adding the diabetes drug sitagliptin to standard medications could better prevent a dangerous immune reaction called graft-versus-host disease (GVHD) after a stem cell transplant. It involved 190 adults with blood cancers who received transplants from partial…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Apr 04, 2026 06:50 UTC
-
Breakthrough blood test could spot dangerous virus earlier in vulnerable transplant patients
Diagnosis CompletedThis study tested a new blood test designed to detect cytomegalovirus (CMV) infection in people who have received a stem cell transplant. Researchers looked back at stored blood samples from 60 transplant patients to see if the new test, which looks for a specific viral marker, w…
Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Sponsor: Ting YANG • Aim: Diagnosis
Last updated Mar 31, 2026 12:12 UTC